Talphera (TLPH) Gains from Sales and Divestitures (2013 - 2026)
Talphera (TLPH) recorded quarterly Gains from Sales and Divestitures of $54760.0 in Q1 2026, down 41.5% quarter-over-quarter from $93606.0 in Q4 2025, and down 21.66% on a YoY basis from $69897.0 in Q1 2025.
Talphera (TLPH) Gains from Sales and Divestitures (2013 - 2026) Analysis & Trends
Talphera's Gains from Sales and Divestitures history runs 9 years deep, the most recent figure standing at $54760.0 for Q1 2026.
- In Q1 2026, Gains from Sales and Divestitures fell 21.66% year-over-year to $54760.0; the TTM figure through Mar 2026 stood at $54760.0 (down 21.66% YoY), while the FY2025 annual figure was $93606.0, up 120.12% from the prior year.
- Gains from Sales and Divestitures was $54760.0 for Q1 2026 at Talphera, down from $93606.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $880315.0 in Q2 2022 to a low of $34606.0 in Q1 2023.
- Historically, Gains from Sales and Divestitures has averaged $137781.1 across 5 years, with a median of $44232.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Gains from Sales and Divestitures plunged 96.07% in 2023, then jumped 138.23% in 2025.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $44744.0 in 2022, then fell by 9.81% to $40356.0 in 2023, then climbed by 5.37% to $42525.0 in 2024, then jumped by 120.12% to $93606.0 in 2025, then sank by 41.5% to $54760.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $54760.0 (Q1 2026), $93606.0 (Q4 2025), and $93606.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54,760.00 |
| Mar 31, 2026 | 54,760.00 |
| Dec 31, 2025 | 93,606.00 |
| Dec 31, 2025 | 93,606.00 |
| Sep 30, 2025 | 93,606.00 |
| Sep 30, 2025 | 93,606.00 |
| Jun 30, 2025 | 93,606.00 |
| Jun 30, 2025 | 93,606.00 |
| Mar 31, 2025 | 69,897.00 |
| Mar 31, 2025 | 69,897.00 |
| Dec 31, 2024 | 42,525.00 |
| Dec 31, 2024 | 42,525.00 |
| Sep 30, 2024 | 39,369.00 |
| Sep 30, 2024 | 39,369.00 |
| Jun 30, 2024 | 39,293.00 |
| Jun 30, 2024 | 39,293.00 |
| Mar 31, 2024 | 39,293.00 |
| Mar 31, 2024 | 39,293.00 |
| Dec 31, 2023 | 40,356.00 |
| Dec 31, 2023 | 40,356.00 |